IFNG and neoplasm: Platelets could induce the release of soluble NKG2D ligands in tumor cells, thus avoiding the recognition of tumor cells by NK cells, meanwhile inhibiting degranulation and secretion of inflammatory factors such as IFN-γ of NK cells (Cluxton et al., 2019).